DIGITAL ALLY, INC ANNOUNCES SECOND QUARTER 2023 OPERATING RESULTS
August 14, 2023 18:00 ET
|
Digital Ally, Inc.
LENEXA, Kansas, Aug. 14, 2023 (GLOBE NEWSWIRE) -- Digital Ally, Inc. (Nasdaq: DGLY) (the “Company” or “our”), today announced its operating results for the second quarter 2023. An investor...
Welltec Q2 2023 Interim Report and Investor Conference Call Announcement
June 23, 2023 06:00 ET
|
Welltec International ApS
Q2 2023 Interim Report and Investor Conference Call Announcement Welltec® will disclose its Q2 2023 Interim Report and will discuss the results during an investor conference call to be held...
Welltec Q1 2023 Interim Report and Investor Conference Call Announcement
April 17, 2023 07:57 ET
|
Welltec International ApS
Q1 2023 Interim Report and Investor Conference Call Announcement Welltec® will disclose its Q1 2023 Interim Report and will discuss the results during an investor conference call to be held Tuesday,...
DIGITAL ALLY, INC ANNOUNCES 2022 OPERATING RESULTS
April 03, 2023 08:45 ET
|
Digital Ally, Inc.
LENEXA, Kansas , April 03, 2023 (GLOBE NEWSWIRE) -- Digital Ally, Inc. (Nasdaq: DGLY) (the “Company” or “our”), today announced its operating results for 2022. An investor conference call is...
DIGITAL ALLY SETS DATE TO ANNOUNCE FOURTH QUARTER 2022 AND YEAR-END OPERATING RESULTS
March 30, 2023 08:20 ET
|
Digital Ally, Inc.
Digital Ally to Discuss Year-End Results, Status of Previously Announced Corporate Spin-Off, and Individual Subsidiary Outlooks. KANSAS CITY, March 30, 2023 (GLOBE NEWSWIRE) -- Digital Ally, Inc....
Vyant Bio Postpones Second Quarter Investor Conference Call and Webcast
August 15, 2022 08:05 ET
|
Vyant Bio, Inc.
CHERRY HILL, N.J., Aug. 15, 2022 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio” or “Company”) (Nasdaq: VYNT) is an innovative biotechnology company reinventing drug discovery for complex...
Vyant Bio Announces Investor Conference Call and Webcast for the Year-End 2021
March 28, 2022 16:30 ET
|
Vyant Bio, Inc.
CHERRY HILL, N.J., March 28, 2022 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio”, “Company”) (Nasdaq: VYNT), is an innovative biotechnology company reinventing drug discovery for complex...
SINTX Technologies Issues 2022 10-K and Announces Investor Conference Call
March 25, 2022 17:41 ET
|
SINTX Technologies, Inc.
SALT LAKE CITY, March 25, 2022 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (www.sintx.com) (NASDAQ: SINT) (“SINTX” or the “Company”), an original equipment manufacturer of advanced ceramics,...
Digital Ally, Inc. Sets Date to Discuss Third Quarter 2021 Operating Results
November 10, 2021 12:30 ET
|
Digital Ally Inc.
Third Quarter 2021 Operating Results conference call to take place on Wednesday, November 17th, 2021, at 11:15 a.m. Eastern Time Lenexa, KS, Nov. 10, 2021 (GLOBE NEWSWIRE) -- Digital Ally, Inc....
MamaMancini's to Host Second Quarter 2022 Earnings Call on Thursday, September 9th at 4:30 p.m. Eastern Time
August 31, 2021 08:31 ET
|
MamaMancini's Holdings, Inc.
EAST RUTHERFORD, N.J, Aug. 31, 2021 (GLOBE NEWSWIRE) -- MamaMancini's Holdings, Inc. (NASDAQ: MMMB), a marketer of specialty pre-prepared, frozen and refrigerated food products, will release...